EIPC Workshop on PCB BioMEMS


Reading time ( words)

The Premier Inn conference centre at Heathrow Airport was the venue for the EIPC workshop on PCB BioMEMS. What, I hear you ask, is a PCB BioMEMS? This is an abbreviation for biomedical (or biological) microelectromechanical systems, otherwise known as lab-on-chip.

Given the strong market pull for more BioMEMS devices (USD $2.5 billion in 2014 and anticipated to grow at CAGR of more than 25% from 2016 to 2023), the commercialization of lab-on-chip devices is currently the Holy Grail of the research community. The lab-on-PCB approach (aka PCB BioMEMS) is being followed in various research groups all over Europe, owing to its inherent upscaling potential: the PCB industry is well-established all around the world, with standardized fabrication facilities and processes is currently commercially exploited only for electronics.

The workshop began with an introduction from Dr. Despina Moschou, 50th Anniversary Prize Fellow/Lecturer at the Centre for Advanced Sensor Technologies at the University of Bath. It was Despina who first introduced the concept of PCB BioMEMS to the EIPC at its Summer Conference in Edinburgh in June 2016, which ignited interest. She asked why lab-on-chip is not already more established using PCB technologies to provide the needed integration between the microfluidics, the biological elements and the electronics required to form an analytical system highlighting the long-standing industrial infrastructure, microfabrication capabilities and intuitive integration of electronics.

The first speaker was Dr. Yuksel Temiz of IBM’s Zurich Research Laboratory. Dr. Temiz explained that although there are over 1,400+ infectious species and 347 significant diseases, less than 5% of their prevalence has been accurately mapped. He postulated that the use of IoT-based devices linked to Smartphones or a handheld reader could revolutionise infectious disease mapping. He contrasted conventional lateral  flow technology, such as that used in pregnancy detectors noting that microfluidics technology would require a much smaller sample size and optimised flow control to give much better quantitative results when used in a portable immunodiagnostic microfluidic platform.

To read the full version of this article which appeared in the February 2017 issue of The PCB Magazine, click here.

Share


Suggested Items

PCB Design, Fabrication and Use from the Mil-Aero End-User Perspective

08/28/2018 | Pete Starkey, I-Connect007
The procedures described for Rolls Royce were directly comparable with those described for MBDA, and the presenters were unanimous in re-emphasising the importance of working closely with their chosen PCB fabricators at all levels and all stages of design, qualification and production of their circuit boards.

Process Control for HDI Fabrication

05/30/2018 | Happy Holden, I-Connect007
A subject that gets very little discussion but is essential to the HDI process is automation. That is, the control of chemical concentrations in our many PCB processes and, especially, those that have been mechanized and can change very rapidly. HDI is one of those series of processes where control is the key to high yields.

HDI’s Beneficial Influence on High-Frequency Signal Integrity

10/17/2017 | Happy Holden, I-Connect007
The increasingly widespread use of finepitch ball-grid array (BGA), chip scale packaging (CSP), and other evolving technology form-factors means that new fabrication techniques must be used to create printed circuit boards (PCBs).



Copyright © 2018 I-Connect007. All rights reserved.